Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies by Yael Bar, Geoffrey Fell, Aylin Dedeoglu, Natalie Moffett, Neelima Vidula, Laura Spring, Seth A. Wander, Aditya Bardia, Naomi Ko, Beverly Moy, Leif W. Ellisen, Steven J. Isakoff

Get full text

Selection biases in the systematic collection of breast biobank specimens by Yael Bar, Gary X. Wang, Gabrielle E. Gioia, Geoffrey Fell, Shinn-Huey S. Chou, Veerle Bossuyt, Steven J. Isakoff, Beverly Moy, Leif W. Ellisen, Constance D. Lehman, Laura M. Spring

Get full text

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2– breast cancer (LEADER) by Laura M. Spring, Lauren Scarpetti, Arielle J. Medford, Andrzej Niemierko, Amy Comander, Therese Mulvey, Lowell Schnipper, Steven J. Isakoff, Beverly Moy, Seth A. Wander, Jennifer Shin, Zanta Ephrem, Anneke R. Laposta, Elyssa Denault, Elizabeth Abraham, Gayle Calistro, Ekaterina Kalashnikova, Angel Rodriguez, Minetta C. Liu, Alexey Aleshin, Jeffrey Peppercorn, Leif W. Ellisen, Aditya Bardia

Get full text